0001209191-23-024898.txt : 20230419
0001209191-23-024898.hdr.sgml : 20230419
20230419180011
ACCESSION NUMBER: 0001209191-23-024898
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230417
FILED AS OF DATE: 20230419
DATE AS OF CHANGE: 20230419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39603
FILM NUMBER: 23830947
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REVELATION BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001810560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 843898466
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4660 LAJOLLA VILLAGE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 650-800-3717
MAIL ADDRESS:
STREET 1: 4660 LAJOLLA VILLAGE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: Petra Acquisition Inc.
DATE OF NAME CHANGE: 20200423
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-17
0
0001810560
REVELATION BIOSCIENCES, INC.
REVB
0001287235
TIDMARSH GEORGE F
C/O REVELATION BIOSCIENCES, INC.
4660 LA JOLLA VILLAGE DR., SUITE 100
SAN DIEGO
CA
92122
1
0
0
0
0
Common Stock
2023-04-17
4
P
0
26500
1.16
A
39848
D
Common Stock
2023-04-18
4
P
0
25000
1.16
A
64848
D
Common Stock
43525
I
By Trust
Represents the weighted-average price at which shares were purchased within a range between $1.14 and $1.17. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.
/s/ J.P. Galda, as attorney-in-fact for George F Tidmarsh
2023-04-19